Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2022	Sep. 30, 2021
CURRENT ASSETS:
Cash	$ 50,444	$ 355,673
Accounts receivable	55,892	57,953
Due from affiliates	1,479,413	2,617,873
Other current assets	26,627	12,221
TOTAL CURRENT ASSETS	1,612,376	3,043,720
NON-CURRENT ASSETS:
Cost method investment	6,602,000
Equity method investment	4,929,381
Intangible assets, net	9,260,888	13,616,116
TOTAL NON-CURRENT ASSETS	20,792,269	13,616,116
TOTAL ASSETS	22,404,645	16,659,836
CURRENT LIABILITIES:
Due to affiliates	4,026,354	4,257,792
Accounts payable and accrued liabilities	561,460	380,721
TOTAL CURRENT LIABILITIES	4,587,814	4,638,513
TOTAL LIABILITIES	4,587,814	4,638,513
CONTINGENCY - (Note 13)
STOCKHOLDERS’ EQUITY:
Preferred stock ($0.0001 par value; 15,000,000 shares authorized; 0 share issued and outstanding at March 31, 2022 and September 30, 2021)
Common stock ($0.0001 par value; 900,000,000 shares authorized; 367,175,886 and 332,024,371 shares issued and outstanding at March 31, 2022 and September 30, 2021, respectively)	36,718	33,203
Additional paid-in capital	24,127,298	14,474,839
Accumulated deficit	(6,366,612)	(2,495,159)
Accumulated other comprehensive income - foreign currency translation adjustment	19,427	8,440
TOTAL STOCKHOLDERS’ EQUITY	17,816,831	12,021,323
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 22,404,645	$ 16,659,836